Theory Paper IDrNB Cardiology – Theory Notes
PRE OP ASSESSMENT OF TOF; CURRENT STATUS; RECOMMENDATIONS
IINTRODUCTION AND EMBRYOLOGICAL DEFINITION
- Morphogenetic Definition (Van Praagh Monology): Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect beyond the neonatal period, resulting from a single primary developmental abnormality: anterocephalad (anterior and superior) malalignment/deviation of the outlet (infundibular/conal) septum relative to the trabecular muscular septum. This single embryological shift produces all four components of the tetrad: (1) a large non-restrictive subaortic malalignment Ventricular Septal Defect (VSD), (2) Right Ventricular Outflow Tract (RVOT) obstruction (subvalvular infundibular, valvular, and/or supravalvular), (3) overriding of the aorta (less than 50 percent override over the RV; >50 percent RV origin is classified as Double Outlet Right Ventricle [DORV]), and (4) concentric Right Ventricular Hypertrophy (RVH) secondary to systemic RV pressure.
- Objectives of Pre-Operative Assessment: To define every level of RVOT and branch pulmonary artery stenosis, measure the pulmonary valve annulus Z-score, exclude anomalous coronary arteries crossing the RVOT, identify additional muscular VSDs or aortopulmonary collaterals, screen for genetic syndromes (22q11.2 deletion), and select the optimal timing for valve-sparing primary repair vs. staged palliation.
IIPRE-OPERATIVE RISK STRATIFICATION
AHigh-Risk Anatomical Features (Dictating Surgical Modification)
- Anomalous Coronary Artery Crossing the RVOT (Present in 5 to 9 Percent of TOF): Most commonly an anomalous Left Anterior Descending (LAD) artery arising from the Right Coronary Artery (RCA) or right sinus of Valsalva, a single coronary ostium, or a large dual LAD/conal branch coursing directly across the anterior subpulmonary infundibulum. Surgical Impact: Precludes a standard transannular ventriculotomy incision (as inadvertent transection causes fatal intraoperative anterior myocardial infarction); mandates either a transatrial-transpulmonary repair, a tailored oblique ventriculotomy parallel to the coronary, a double-barrel technique, or an extracardiac RV-to-PA conduit.
- Hypoplastic Branch Pulmonary Arteries and Annular Z-Score:
- Pulmonary Valve Annulus Z-Score: A Z-score greater than -2 to -3 generally permits valve-sparing repair, whereas a severely hypoplastic annulus (Z-score less than -3 to -4) predicts the requirement for a Transannular Patch (TAP).
- Nakata Index (PAI) and McGoon Ratio: A Nakata Index less than 150 mm2/m2 or McGoon Ratio less than 1.2 indicates severe branch pulmonary artery hypoplasia, predicting suprasystemic post-repair RV pressure and favoring initial palliation (RVOT stent or mBTT shunt) to grow the pulmonary arterial tree before VSD closure.
- Major Aortopulmonary Collateral Arteries (MAPCAs) and Discontinuous PAs: Present in TOF with Pulmonary Atresia (PA-VSD); mandates complete preoperative CTA + catheter mapping to plan surgical unifocalization.
- Additional (“Swiss-Cheese”) Apical Muscular VSDs or Complete AVSD (“Tet-Canal”): Unrecognized second muscular VSDs cause acute postoperative left-to-right volume overload and heart failure after RVOT relief, while TOF with complete Atrioventricular Septal Defect (strongly associated with Down Syndrome / Trisomy 21) requires complex two-patch or modified single-patch repair.
BClinical, Syndromic, and STAT Mortality Risk Factors
- Patient Factors: Prematurity, low birth weight (less than 2.5 kg), and prostaglandin-dependent neonatal cyanosis or refractory ventilated hypercyanotic spells carry higher morbidity with neonatal bypass and often favor initial transcatheter RVOT/PDA stenting.
- Genetic Syndromes (Present in 20 to 30 Percent of TOF):
- 22q11.2 Microdeletion (DiGeorge / Velocardiofacial Syndrome — Present in ~15% of classical TOF and up to 40–50% of TOF with Pulmonary Atresia or Right Aortic Arch): Mandates preoperative screening (FISH / chromosomal microarray) because thymic hypoplasia requires irradiated, leukoreduced blood products (to prevent fatal transfusion-associated graft-versus-host disease), parathyroid hypoplasia causes severe perioperative hypocalcemia, and velopharyngeal/airway anomalies complicate extubation.
- Other Associations: Trisomy 21 (associated with TOF + AVSD), Alagille Syndrome (JAG1) (peripheral branch PA stenosis + cholestasis), and CHARGE / VACTERL associations.
- STAT Mortality Categories (Society of Thoracic Surgeons — EACTS): Standard primary TOF repair is STAT Category 1 to 2 (operative mortality ~1 percent), whereas TOF with Pulmonary Atresia and MAPCAs or neonatal repair with severe comorbidities rises to STAT Category 4.
IIIMULTIMODALITY PRE-OPERATIVE DIAGNOSTIC ALGORITHM
| Imaging Modality | Guideline Status | Specific Pre-Operative Parameters Evaluated |
|---|---|---|
| Transthoracic Echocardiography (TTE) | Class I (Mandatory First-Line in All Patients) | Malalignment VSD size & <50% aortic override (excludes DORV); multilevel RVOT obstruction; PV annulus diameter & Z-score; proximal coronary origins; Right Aortic Arch (present in 25%); additional muscular VSDs, ASD/PFO, PDA, and Left SVC to Coronary Sinus (10%) |
| Cardiac CT Angiography (MDCTA) | Class I / IIa (Non-Invasive Reference for Extracardiac & Coronary Anatomy) | Definitive exclusion of anomalous LAD crossing RVOT; 3D branch PA measurements (Nakata Index & McGoon Ratio); aortic arch branching (aberrant subclavian artery); and complete mapping of MAPCAs |
| Cardiac Catheterization & Angiography | Class III for Routine Uncomplicated TOF; Class I for Specific Hemodynamic/Interventional Indications | Reserved for: (1) TOF with PA & MAPCAs (measuring distal segmental MAPCA pressures and proving dual vs. sole supply); (2) Coiling large dual-supply APCs; (3) RVOT or PDA stenting; or (4) assessing PVR in rare late-presenting pink TOF |
IVPRE-OPERATIVE MEDICAL STABILIZATION AND TET SPELL PROTOCOL
- Hypercyanotic Spell Emergency Protocol:
- Physical Maneuver & Oxygen: Knee-chest position (increases SVR) and 100% humidified oxygen.
- Sedation and Hyperpnea Suppression: Morphine Sulfate 0.1 to 0.2 mg/kg IV, IM, or SC (or Ketamine 1 to 2 mg/kg IV / 3 to 5 mg/kg IM).
- Volume Expansion and Acidosis Correction: Isotonic crystalloid bolus 10 to 20 mL/kg IV (increases RV preload) and Sodium Bicarbonate 1 to 2 mEq/kg IV if metabolic acidosis persists.
- Relief of Dynamic Infundibular Spasm (Class I): Esmolol 500 mcg/kg (0.5 mg/kg) IV bolus over 1 minute followed by 50 to 200 mcg/kg/min infusion, or Propranolol 0.05 to 0.15 mg/kg slow IV push.
- SVR Augmentation (Refractory Spells): Phenylephrine 5 to 20 mcg/kg IV bolus followed by 0.1 to 0.5 mcg/kg/min infusion.
- Outpatient Pre-Surgical Optimization: Oral Propranolol (1 to 4 mg/kg/day) for spell prophylaxis, oral iron supplementation (to maintain MCV >80 fL and prevent microcytic hyperviscosity stroke), dental/infection clearance, and avoidance of dehydration.
VCURRENT SURGICAL TIMING AND VALVE-SPARING RECOMMENDATIONS (AATS / STS CONSENSUS)
- Elective Primary Repair at 3 to 6 Months of Age (Class I): Asymptomatic or mildly cyanotic infants with standard anatomy undergo elective single-stage complete repair between 3 and 6 months of age (performing repair before 3 months increases transannular patch rates and ICU stay, while delaying beyond 12 months increases chronic hypoxia, RV hypertrophy/fibrosis, and spell morbidity).
- Symptomatic Neonates (<30 Days) or Weight <2.5 kg: High-volume neonatal centers may perform primary neonatal repair in selected cases, but staged palliation—preferentially via transcatheter RVOT Stenting (or PDA stenting / surgical mBTT shunt)—followed by complete repair at 4 to 8 months achieves lower early morbidity and allows the pulmonary annulus to grow for a subsequent valve-sparing repair.
- The Valve-Sparing Transatrial-Transpulmonary Paradigm: To prevent late RV failure from chronic free pulmonary regurgitation, contemporary surgery prioritizes a transatrial-transpulmonary approach combining infundibular muscle resection through the tricuspid valve, pulmonary commissurotomy, and intraoperative balloon dilation of the pulmonary annulus to preserve the native valve whenever the pulmonary annulus Z-score is -2.5 to -3.0 or greater.
Key references
- Expert Consensus Panel (Villafañe J, Feinstein JA, Jenkins KJ, et al.): Hot Topics in Tetralogy of Fallot, Journal of the American College of Cardiology, 2013.
- Miller JR, Stephens EH, Goldstone AB, et al. (AATS Expert Consensus): The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot, Journal of Thoracic and Cardiovascular Surgery, 2023.
- Baumgartner H, De Backer J, Babu-Narayan SV, et al.: 2020 ESC Guidelines for the management of adult congenital heart disease, European Heart Journal, 2020.
meritmedscript.comDr. Sidhartha Mullapudi
